The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 25, 2022

Filed:

Jul. 30, 2021
Applicant:

Cagent Vascular, Inc., Wayne, PA (US);

Inventors:

Peter Schneider, Honolulu, HI (US);

Robert Giasolli, Orange, CA (US);

Assignee:

Cagent Vascular, Inc., Wayne, PA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 25/10 (2013.01); A61M 37/00 (2006.01); A61B 17/20 (2006.01); A61B 17/22 (2006.01); A61B 17/00 (2006.01); A61B 17/3207 (2006.01); A61M 25/00 (2006.01);
U.S. Cl.
CPC ...
A61M 25/104 (2013.01); A61B 17/205 (2013.01); A61B 17/320725 (2013.01); A61M 25/1011 (2013.01); A61M 25/1027 (2013.01); A61B 2017/00004 (2013.01); A61B 2017/22061 (2013.01); A61M 2025/0096 (2013.01); A61M 2025/105 (2013.01); A61M 2025/109 (2013.01); A61M 2025/1013 (2013.01); A61M 2025/1031 (2013.01); A61M 2025/1059 (2013.01); A61M 2025/1084 (2013.01); A61M 2025/1086 (2013.01); A61M 2037/003 (2013.01); A61M 2037/0023 (2013.01); A61M 2037/0046 (2013.01);
Abstract

A device and method for intravascular treatment of atherosclerotic plaque prior to balloon angioplasty which microperforates the plaque with small sharp spikes acting as serrations for forming cleavage lines or planes in the plaque. The spikes may also be used to transport medication into the plaque. The plaque preparation treatment enables subsequent angioplasty to be performed at low balloon pressures of about 4 atmospheres or less, reduces dissections, and avoids injury to the arterial wall. The subsequent angioplasty may be performed with a drug-eluting balloon (DEB) or drug-coated balloon (DCB). The pre-angioplasty perforation procedure enables more drug to be absorbed during DEB or DCB angioplasty, and makes the need for a stent less likely. Alternatively, any local incidence of plaque dissection after balloon angioplasty may be treated by applying a thin, ring-shaped tack at the dissection site only, rather than applying a stent over the overall plaque site.


Find Patent Forward Citations

Loading…